These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18606975)

  • 1. Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history.
    Rudolph T; Kurz MW; Farbu E
    Clin Med Res; 2008 Sep; 6(2):80-2. PubMed ID: 18606975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan.
    Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A
    Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
    Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G
    J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: Does genetic risk affect family functioning?
    Lopes A; Rodrigues C; Fonseca I; Sousa A; Branco M; Coelho T; Sequeiros J; Freitas P
    Clin Genet; 2018 Nov; 94(5):401-408. PubMed ID: 30019395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis.
    Koike H; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Tanaka F; Sobue G
    Amyloid; 2011 Jun; 18(2):53-62. PubMed ID: 21463231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area.
    Takahashi R; Ono K; Shibata S; Nakamura K; Komatsu J; Ikeda Y; Ikeda T; Samuraki M; Sakai K; Iwasa K; Kayano D; Yamada M
    J Neurol Sci; 2014 Oct; 345(1-2):231-5. PubMed ID: 25060417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloidogenic transthyretin Val30Met homozygote showing unusually early-onset familial amyloid polyneuropathy.
    Tojo K; Sekijima Y; Machida K; Tsuchiya A; Yazaki M; Ikeda S
    Muscle Nerve; 2008 Jun; 37(6):796-803. PubMed ID: 18506713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Familial amyloid polyneuropathy: clinicopathological aspects].
    Koike H; Sobue G
    Brain Nerve; 2014 Jul; 66(7):749-62. PubMed ID: 24998820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met.
    Dardiotis E; Koutsou P; Zamba-Papanicolaou E; Vonta I; Hadjivassiliou M; Hadjigeorgiou G; Cariolou M; Christodoulou K; Kyriakides T
    J Neurol Sci; 2009 Sep; 284(1-2):158-62. PubMed ID: 19493541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy.
    Tojo K; Tsuchiya-Suzuki A; Sekijima Y; Morita H; Sumita N; Ikeda S
    Amyloid; 2010 Mar; 17(1):32-5. PubMed ID: 20132088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.
    Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG
    Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic and genetic features of early- and late-onset FAP type I (FAP ATTR Val30Met) in Japan.
    Sobue G; Koike H; Misu K; Hattori N; Yamamoto M; Ikeda S; Ando Y; Nakazato M; Inukai A
    Amyloid; 2003 Aug; 10 Suppl 1():32-8. PubMed ID: 14640040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus.
    Kato-Motozaki Y; Ono K; Shima K; Morinaga A; Machiya T; Nozaki I; Shibata-Hamaguchi A; Furukawa Y; Yanase D; Ishida C; Sakajiri K; Yamada M
    J Neurol Sci; 2008 Jul; 270(1-2):133-40. PubMed ID: 18410945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.
    Ikeda S; Nakazato M; Ando Y; Sobue G
    Neurology; 2002 Apr; 58(7):1001-7. PubMed ID: 11940682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation.
    Lipowska M; Drac H; Rowczenio D; Gilbertson J; Hawkins PN; Lasek-Bal A; Szewczuk J; Grzybowski J; Gawor M; Stępień-Wojno M; Franaszczyk M; Brydak-Godowska J; Śmierciak R; Ptasińska-Perkowska A; Chandoga J; Petrovic R; Kostera-Pruszczyk A
    Neurol Neurochir Pol; 2020; 54(6):552-560. PubMed ID: 33373035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.
    Misu Ki; Hattori N; Nagamatsu M; Ikeda Si; Ando Y; Nakazato M; Takei Yi; Hanyu N; Usui Y; Tanaka F; Harada T; Inukai A; Hashizume Y; Sobue G
    Brain; 1999 Oct; 122 ( Pt 10)():1951-62. PubMed ID: 10506096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial amyloidotic polyneuropathies].
    Vallat JM; Funalot B; Faugeras F; Magy L
    Bull Acad Natl Med; 2012 Oct; 196(7):1321-9; discussion 1329-31. PubMed ID: 23815017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A sporadic case of late-onset familial amyloid polyneuropathy type I (transthyretin Met 30-associated familial amyloid polyneuropathy) inborn habitant of Ehime prefecture].
    Harada T; Ishizaki F; Togo M; Yamashita H; Nitta K; Date Y; Nakazato M; Yamamura Y; Nakamura S
    No To Shinkei; 2002 Jul; 54(7):615-9. PubMed ID: 12187722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area.
    Andrés N; Poza JJ; Martí Massó JF
    Neurologia (Engl Ed); 2018; 33(9):583-589. PubMed ID: 27793437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy.
    Murakami T; Yokoyama T; Mizuguchi M; Toné S; Takaku S; Sango K; Nishimura H; Watabe K; Sunada Y
    J Neurochem; 2021 Mar; 156(6):957-966. PubMed ID: 32852783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.